The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

A screenwriter for Back to the Future issued a savage response after being questioned on a possible fourth sequel. The sci-fi ...

Conductor Daniel Barenboim says he has been diagnosed with Parkinson’s disease. The 82-year-old issued a statement Thursday ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

The writer of Back To The Future, Bob Gale, has given a blunt reaction to the idea of there ever being a fourth film.

Gain's lead program in Parkinson's disease has been awarded funding support from The Michael J. Fox Foundation for ...